红细胞同种免疫妊娠的新生儿与产科结局
该研究在大型医院系统内回顾6年间孕母红细胞抗体筛查阳性的所有活产儿,共707例(3.0/1000活产),其中676例暴露于同种抗体。结果显示,DAT阳性且抗原阳性的抗Rh抗体所致新生儿疾病最重,全部换血与红细胞输注均源于抗Rh同种免疫。
要点
- 孕母抗体筛查阳性率约3.0/1000活产,4%仅由Rh免疫球蛋白所致。
- 抗Rh抗体(c、C、D、e、E)DAT阳性者新生儿病最重,全部输血与换血均由此引起。
- 抗M、S、Duffy、Kidd A、Lewis者无需因高胆红素血症或输血入NICU。
核心结论
- 抗Rh同种免疫仍是该院系统内严重HDFN的主要原因。
- 对同种免疫母亲所生新生儿,DAT阳性并显示抗原阳性是贫血与高胆红素血症的最佳预测指标。
研究设计与样本
- 回顾性总结6年间孕母红细胞抗体筛查阳性后的所有活产儿特征与结局。
- 共纳入707例新生儿,其中676例暴露于同种抗体。
主要发现
- 抗体筛查阳性率为3.0/1000活产,31例(4%)阳性仅由Rh免疫球蛋白所致。
- 676例暴露者中,受检者37% DAT阳性并显示抗原阳性及HDFN证据。
- DAT阳性抗Rh抗体(c、C、D、e、E)者新生儿疾病最重。
- 全部15例新生儿红细胞输注与6例换血均由抗Rh同种免疫所致。
- 抗M、抗S、抗Duffy、抗Kidd A或抗Lewis母亲所生新生儿无需因高胆红素血症或输血入NICU。
关键数值与推荐
- 孕母抗体筛查阳性率3.0/1000活产。
- 31/707(4%)阳性仅由Rh免疫球蛋白所致。
- 676例暴露者中受检者37% DAT阳性并见抗原阳性与HDFN证据。
- 红细胞输注15例、换血6例均归因于抗Rh同种免疫。
临床怎么用
- 对同种免疫母亲所生新生儿,应重视DAT结果并结合抗原阳性判断贫血与高胆红素血症风险。
- 抗Rh抗体(c、C、D、e、E)者需警惕严重HDFN,必要时准备输血或换血。
- 抗M、S、Duffy、Kidd A、Lewis者发生需NICU处理的高胆红素血症或输血风险低。
局限性
- 原文摘要未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Despite advances in the prevention of rhesus (Rh)(D) alloimmunization, alloantibodies to Rh(D) and non-Rh(D) red blood cell antigens continue to be detected in ∼4% of US pregnancies and can result in hemolytic disease of the fetus and newborn (HDFN). Recent reports on HDFN lack granularity and are unable to provide antibody-specific outcomes. The objective of this study was to calculate the frequency of alloimmunization in our large hospital system and summarize the outcomes based on antibody specificity, titer, and other clinical factors. METHODS: We identified all births in a 6-year period after a positive red blood cell antibody screen result during pregnancy and summarized their characteristics and outcomes. RESULTS: A total of 707 neonates were born after a positive maternal antibody screen result (3.0/1000 live births). In 31 (4%), the positive screen result was due to rhesus immune globulin alone. Of the 676 neonates exposed to alloantibodies, the direct antibody test (DAT) result was positive, showing antigen-positivity and evidence of HDFN in 37% of those tested. Neonatal disease was most severe with DAT-positive anti-Rh antibodies (c, C, D, e, E). All neonatal red blood cell transfusions (15) and exchange transfusions (6) were due to anti-Rh alloimmunization. No neonates born to mothers with anti-M, anti-S, anti-Duffy, anti-Kidd A, or anti-Lewis required NICU admission for hyperbilirubinemia or transfusion. CONCLUSIONS: Alloimmunization to Rh-group antibodies continues to cause a majority of the severe HDFN cases in our hospital system. In neonates born to alloimmunized mothers, a positive DAT result revealing antigen-positivity is the best predictor of anemia and hyperbilirubinemia.
引用
- Bahr TM, Tweddell SM, Zalla JM, et al. Neonatal and Obstetrical Outcomes of Pregnancies Complicated by Alloimmunization. Pediatrics. 2024. PMID: 38784990. doi:10.1542/peds.2023-064604
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。